Related Experiment Video
Updated: May 8, 2026
11:27
A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α
Published on: November 2, 2018
Emerging from NF-κB's shadow, SUMOylated IκBα represses transcription
1Institute for Cell and Molecular Biosciences, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne NE2 4HH, UK. neil.perkins@ncl.ac.uk
Cancer Cell
|August 17, 2013
Summary
This study reveals a new role for SUMOylated IκBα (inhibitor of kappa B-alpha) in gene silencing, independent of NF-κB signaling. This finding connects inflammatory pathways to skin cell balance and Polycomb repressor activity.
Area of Science:
- Molecular Biology
- Cellular Signaling
- Dermatology
Background:
- Nuclear Factor-kappa B (NF-κB) signaling is a key regulator of inflammation and immunity.
- IκBα (inhibitor of kappa B-alpha) is a known inhibitor of NF-κB.
- SUMOylation is a post-translational modification that can alter protein function.
Purpose of the Study:
- To investigate the function of SUMOylated IκBα beyond its role in NF-κB inhibition.
- To explore the potential link between inflammatory signaling and skin homeostasis.
- To elucidate the interaction between IκBα and Polycomb group (PcG) repressors.
Main Methods:
- Western blotting to detect SUMOylated IκBα.
- Immunoprecipitation assays to study protein interactions.
- Reporter gene assays to assess transcriptional activity.
- In vivo studies in mouse models of skin inflammation.
Main Results:
- SUMOylated IκBα exhibits a transcriptional repression function independent of NF-κB.
- SUMOylated IκBα interacts with components of the Polycomb repressor complex.
- This interaction mediates the repression of specific target genes involved in skin homeostasis.
- Inflammatory signaling can modulate the SUMOylation status of IκBα, thereby influencing skin cell differentiation and proliferation.
Conclusions:
- SUMOylated IκBα acts as a novel link between inflammatory signaling and epigenetic regulation via Polycomb repressors.
- This mechanism provides new insights into the maintenance of skin homeostasis.
- Targeting SUMOylation of IκBα may offer therapeutic strategies for inflammatory skin diseases.
Related Concept Videos
02:26NF-κB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
02:04Co-activators and Co-repressors
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
02:04Co-activators and Co-repressors
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
01:52Eukaryotic Transcription Inhibitors
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
02:26NF-kB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
02:36RNA Polymerase II Accessory Proteins
Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...